TRANSMEDICS GROUP INC (1TMDX.MI) Stock Price & Overview
BIT:1TMDX • US89377M1099
Current stock price
The current stock price of 1TMDX.MI is 87.2 EUR. Today 1TMDX.MI is down by -23.31%.
1TMDX.MI Key Statistics
- Market Cap
- 2.991B
- P/E
- 36.33
- Fwd P/E
- 41.14
- EPS (TTM)
- 2.40
- Dividend Yield
- N/A
1TMDX.MI Stock Performance
1TMDX.MI Stock Chart
1TMDX.MI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to 1TMDX.MI.
1TMDX.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 1TMDX.MI. 1TMDX.MI has only an average score on both its financial health and profitability.
1TMDX.MI Earnings
On February 24, 2026 1TMDX.MI reported an EPS of 0.53 and a revenue of 160.76M. The company beat EPS expectations (32.92% surprise) and beat revenue expectations (1.22% surprise).
1TMDX.MI Forecast & Estimates
20 analysts have analysed 1TMDX.MI and the average price target is 141.32 EUR. This implies a price increase of 62.06% is expected in the next year compared to the current price of 87.2.
For the next year, analysts expect an EPS growth of -11.67% and a revenue growth 23.07% for 1TMDX.MI
1TMDX.MI Groups
Sector & Classification
1TMDX.MI Financial Highlights
Over the last trailing twelve months 1TMDX.MI reported a non-GAAP Earnings per Share(EPS) of 2.4. The EPS increased by 178.22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 31.43% | ||
| ROA | 17.81% | ||
| ROE | 40.22% | ||
| Debt/Equity | 1.06 |
1TMDX.MI Ownership
1TMDX.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 14.11 | 94.288B | ||
| SHL | SIEMENS HEALTHINEERS AG | 14.51 | 43.259B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 16.27 | 23.765B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 16.26 | 23.727B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 15.63 | 23.014B | ||
| BIM | BIOMERIEUX | 19.02 | 10.783B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 19.65 | 3.743B | ||
| DIA | DIASORIN SPA | 15.49 | 3.474B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 14.87 | 2.481B | ||
| 1AFX | CARL ZEISS MEDITEC AG - BR | 12.37 | 2.274B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.92 | 1.818B | ||
| DRW8 | DRAEGERWERK AG | 9.18 | 1.407B | ||
| ELN | EL.EN. SPA | 17.58 | 1.055B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find more growth stocks the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1TMDX.MI
Company Profile
TransMedics Group, Inc. operates as a commercial stage medical technology company. The company is headquartered in Andover, Massachusetts and currently employs 898 full-time employees. The company went IPO on 2019-05-02. The firm specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. The company also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Company Info
IPO: 2019-05-02
TRANSMEDICS GROUP INC
200 Minuteman Road
Andover MASSACHUSETTS US
Employees: 898
Phone: 19785520900
TRANSMEDICS GROUP INC / 1TMDX.MI FAQ
Can you describe the business of TRANSMEDICS GROUP INC?
TransMedics Group, Inc. operates as a commercial stage medical technology company. The company is headquartered in Andover, Massachusetts and currently employs 898 full-time employees. The company went IPO on 2019-05-02. The firm specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. The company also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Can you provide the latest stock price for TRANSMEDICS GROUP INC?
The current stock price of 1TMDX.MI is 87.2 EUR. The price decreased by -23.31% in the last trading session.
Does 1TMDX stock pay dividends?
1TMDX.MI does not pay a dividend.
How is the ChartMill rating for TRANSMEDICS GROUP INC?
1TMDX.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Would investing in TRANSMEDICS GROUP INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1TMDX.MI.
What is TRANSMEDICS GROUP INC worth?
TRANSMEDICS GROUP INC (1TMDX.MI) has a market capitalization of 2.99B EUR. This makes 1TMDX.MI a Mid Cap stock.
Can you provide the upcoming earnings date for TRANSMEDICS GROUP INC?
TRANSMEDICS GROUP INC (1TMDX.MI) will report earnings on 2026-05-05.